Cargando…
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
Cysteine proteases continue to provide validated targets for treatment of human diseases. In neurodegenerative disorders, multiple cysteine proteases provide targets for enzyme inhibitors, notably caspases, calpains, and cathepsins. The reactive, active-site cysteine provides specificity for many in...
Autores principales: | Siklos, Marton, BenAissa, Manel, Thatcher, Gregory R.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675809/ https://www.ncbi.nlm.nih.gov/pubmed/26713267 http://dx.doi.org/10.1016/j.apsb.2015.08.001 |
Ejemplares similares
-
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018) -
Odanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In Vivo
por: Vermeire, Jon J., et al.
Publicado: (2016) -
Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
por: Phan, Hoang Anh T., et al.
Publicado: (2021) -
Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
por: Quilles Junior, José C., et al.
Publicado: (2019) -
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
por: Lewandowski, Cutler T., et al.
Publicado: (2021)